✨ Your Portfolio is fetched and updated from zerodha.
Nano Pharmaceuticals
Market Cap
₹181 Cr.
P/E
18.50
  • Bio Medica Labs.
  • Zenotech Labs.
  • Shukra Pharmaceut.

FAQs on Bio Medica Laboratories Ltd. Shareprice

There is not enough historical data for the companies share price.

There is insufficient historical data to gauge this.
Latest PE of Bio Medica Labs. is 18.5

Growth Table

  • Bio Medica Laboratories Ltd.
  • Zenotech Labs.
  • Shukra Pharmaceut.

Balance Sheet

  • Bio Medica Laboratories Ltd.
  • Zenotech Labs.
  • Shukra Pharmaceut.

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Bio Medica Laboratories Ltd.
  • Zenotech Labs.
  • Shukra Pharmaceut.

Cash Flow

  • Bio Medica Laboratories Ltd.
  • Zenotech Labs.
  • Shukra Pharmaceut.

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Bio Medica Laboratories Ltd.
  • Zenotech Labs.
  • Shukra Pharmaceut.

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*

FAQs on Bio Medica Laboratories Ltd. Financials

Balance sheet of Bio Medica Labs. is strong.
But short term working capital might become an issue for this company.

Yes, The net debt of Bio Medica Labs. is increasing.
Latest net debt of Bio Medica Labs. is ₹15.01 Crs as of Mar-25.
This is greater than Mar-24 when it was ₹10.48 Crs.

Yes, profit is increasing.
The profit of Bio Medica Labs. is ₹9.79 Crs for Mar 2025, ₹2.5 Crs for Mar 2024 and ₹0.33 Crs for Mar 2023

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Bio Medica Labs. latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are allocated to majorly unproductive assets like Inventory, Short Term Loans & Advances

Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech